COVID-19 in the UK in 2026: What UKHSA Data Shows

Unlike the more pronounced summer rise seen in parts of the US, the UK's COVID-19 picture through 2026 has been comparatively steady. That doesn't mean nothing is happening, just that it's being tracked closely rather than making headlines.

Baseline circulation, not elimination

By spring 2026, official reporting described COVID-19 activity in the UK as having settled at baseline circulation, meaning the virus continues to spread at a relatively stable, predictable level rather than surging or disappearing. UKHSA and the World Health Organization have continued routine monitoring throughout the year, watching for any signs of a meaningful shift rather than responding to an active crisis.

Which variants have dominated in 2026

Two lineages have accounted for the large majority of UK cases through the year: XFG, nicknamed "Stratus," and NB.1.8.1, nicknamed "Nimbus." Both descend from the Omicron family and their relative prevalence has shifted through the year according to UKHSA's national flu and COVID-19 surveillance reports. In January 2026, XFG accounted for roughly 32% of sequenced cases and NB.1.8.1 around 25%. By February, the two were roughly level at around 36% each. By May, XFG had settled around 25% while NB.1.8.1 had fallen to around 8%, with other lineages making up a growing share as the season progressed. Neither variant has been linked to increased severity compared with earlier Omicron descendants.

What symptoms have looked like in 2026

Clinical reporting through the year has pointed to a severe sore throat as the most frequently reported primary symptom, alongside the now-familiar pattern of fatigue, cough and headache that has characterised recent variants. This is a noticeably different symptom profile from the earliest pandemic variants, which were more strongly associated with loss of smell and taste and reflects both viral evolution and the effect of widespread population immunity on how the illness typically presents.

Hospital activity

NHS monthly COVID-19 hospital publications have continued through 2026, feeding into the wider UKHSA surveillance picture. Official statistics have not indicated a departure from the baseline pattern described above, with hospital activity data published regularly on the NHS England statistics site for anyone who wants to check current figures directly.

Vaccination programme activity

The UK ran its Spring 2026 booster programme from 13 April to 30 June, targeted at adults aged 75 and over, care home residents and people with weakened immune systems and the Autumn/Winter 2026 programme is scheduled to run from 1 October 2026 to 31 January 2027 for the same groups. This twice-yearly approach for higher-risk groups, alongside a single annual dose for the wider eligible population, is designed to keep protection topped up as immunity from previous doses wanes over time.

How the UK compares with the summer rise seen elsewhere

The more pronounced summer uptick reported in parts of the United States hasn't been mirrored in UK figures to the same degree, though a seasonal rise is generally expected as autumn approaches regardless of any summer trend. Differences in vaccine uptake, population immunity and the timing of variant dominance between the two countries all likely play a role in why the two pictures have looked different this year.

How UK figures are collected

UKHSA's surveillance system draws on several data sources simultaneously, including laboratory-confirmed cases, hospital admission figures reported through NHS trusts and genomic sequencing of a representative sample of positive tests. Combining these sources gives a more reliable picture than any single measure alone, since testing behaviour and healthcare-seeking patterns can shift over time in ways that might otherwise distort the underlying trend.

Regional variation across the UK

National figures can mask meaningful differences between regions and UKHSA's reporting has continued to break down data by NHS region alongside the national picture. Local outbreaks or clusters can push activity higher in specific areas even when the UK-wide trend looks stable, which is part of why regional and local data is published alongside the national headline figures for anyone who wants a more precise local picture.

What's expected as autumn approaches

Respiratory illness in the UK typically rises through autumn and winter as people spend more time indoors in close contact with one another and COVID-19 has followed a broadly similar pattern since settling into endemic circulation. The Autumn/Winter 2026 booster programme has been timed deliberately to build protection among eligible groups ahead of this expected seasonal increase, rather than in response to it.

Comparing 2026 with the year before

Year-on-year comparisons are useful for spotting genuine trends rather than reacting to short-term noise in the data. UKHSA's continued weekly publication of surveillance reports means anyone interested can track how 2026's figures compare with the equivalent period in 2025, offering a clearer sense of whether the virus is behaving similarly to previous years or shifting into a genuinely new pattern.

What this means for planning ahead

For most people in the UK, the current data doesn't call for any change to everyday plans. It's more useful as background context for specific decisions, such as timing a visit to a new baby or an elderly relative, or deciding whether to book an Autumn/Winter booster appointment as soon as invitations open rather than leaving it until later in the programme window when demand tends to be higher.

Anyone wanting a deeper historical view can also compare current figures against the cumulative, final pandemic-era totals published on our COVID-19 statistics page, which draws a clear line between the scale of the original pandemic and today's much smaller, steadier baseline level of circulation.

A quick recap

COVID-19 in the UK has remained at a relatively stable baseline level through 2026, dominated by the XFG and NB.1.8.1 variants, with UKHSA continuing routine weekly surveillance throughout. Symptoms have generally been mild, led by sore throat rather than the classic early-pandemic symptom pattern and the Autumn/Winter 2026 booster programme is the next scheduled opportunity for eligible groups to top up their protection.

Frequently asked questions

Where can I check the latest UK COVID-19 figures myself?

The UKHSA data dashboard is updated weekly and covers case rates, hospital activity and variant prevalence for England, with equivalent dashboards published by the devolved health authorities in Scotland, Wales and Northern Ireland.

Is the UK due a bigger wave later in 2026?

A seasonal rise heading into autumn and winter is the normal, expected pattern, similar to flu. Whether it becomes a particularly large wave depends on factors that are difficult to predict in advance, including which variants are dominant and how vaccine uptake tracks through the Autumn/Winter programme.

Has the UK reintroduced any COVID-19 restrictions in 2026?

No. There's no legal requirement to self-isolate or wear a mask in the UK and current guidance continues to treat COVID-19 similarly to other seasonal respiratory illnesses, based on general public health advice rather than legal mandates.

How does UKHSA know which variants are circulating?

UKHSA sequences a representative sample of positive tests collected through its surveillance network, then uses that sample to estimate the proportion of cases attributable to each variant nationally, publishing updated figures in its weekly reports.

Is sore throat now the main COVID-19 symptom to watch for?

It's been the most frequently reported primary symptom in 2026, but COVID-19 can still present with a wide range of symptoms including fatigue, cough, headache and fever. Testing remains the only reliable way to confirm COVID-19 specifically rather than another respiratory illness.